Biophytis S.A.
BPTSY
Get informed when a big investor buys or sells
+ FollowMarket Cap$2.61M
Close$
Share Statistics
| Market cap | $2.61 Million |
|---|---|
| Enterprise Value | $10.13 Million |
| Dividend Yield | $NaN (NaN%) |
| Earnings per Share | $- |
| Beta | - |
| Outstanding Shares | - |
Return
| Return on Equity | 357.68% |
|---|---|
| Return on Assets | -262.08% |
| Return on Invested Capital | 377.24% |
Valuation & Multiples
| P/E Ratio | - |
|---|---|
| PEG | - |
| Price to Sales | - |
| Price to Book Ratio | - |
| Enterprise Value to Revenue | - |
| Enterprise Value to EBIT | -0.5 |
| Enterprise Value to Net Income | -1 |
| Total Debt to Enterprise | 0.96 |
| Debt to Equity | -1.52 |
Revenue Sources
No data
Insider Trades
Institutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
ESG Score
No data
About Biophytis
2,020 employees
CEO: Stanislas Veillet Biophytis S.A. is a clinical-stage biotechnology company dedicated to creating therapies designed to mitigate age-related degenerative processes and enhance functional well-being for patients. The company's scientific approach centers on...